跳至主要内容
临床试验/CTRI/2019/11/021930
CTRI/2019/11/021930招募中2 期

Efficacy of individualized homeopathic medicines in treatment of dyslipidemia: Double-blind, randomized, placebo-controlled clinical trial

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Newly diagnosed dyslipidemia patients not undergoing any therapy (LDLc level more than 100)
  • 2. Age 18-65 years
  • 3. Both sexes
  • 4. Providing written informed consent

排除标准

  • 1. Familial hypertriglyceridemia
  • 2. Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study
  • 3. Diagnosed cases of systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
  • 4. Pregnancy and lactation
  • 5. Substance abuse and/or dependence
  • 6. Self-reported immune-compromised state, and
  • 7. Undergoing homeopathic treatment for chronic disease within last 6 months.

研究者

发起方
ational Institute of Homoeopathy

相似试验